July 19, 2018—A new report by a key government watchdog confirms the crucial role 340B hospitals play in providing care to low-income patients. In its report to Congress, the Government Accountability Office (GAO) found that disproportionate share hospitals (DSH) participating in the 340B drug pricing program provide more uncompensated and unreimbursed care than acute care … [Read more...]
Death, Taxes…and Drug Price Increases
July 6, 2018—There’s new evidence that pharmaceutical manufacturers have not gotten the message that the Trump administration and the American public want an end to rising drug prices. Research documenting a host of drug price increases in June and July above the rate of inflation could complicate the Trump administration’s advocacy for its drug pricing blueprint, which … [Read more...]
GAO Takes a Closer Look at 340B Contract Pharmacies in New Report
June 29, 2018—Healthcare providers in the 340B drug pricing program pass their savings along to low-income, underinsured patients through drug discounts at their in-house pharmacies or those they contract with, reduced fees at contract pharmacies, or in the form of charity care including free or discounted prescriptions, a new federal report has found. The June 28 Government … [Read more...]
Survey Says: All 340B Hospitals Use Program Savings to Care for Low-Income, Rural Patients
June 25, 2018—Rapid City Hospital in Rapid City, S.D., depends on money it saves through the 340B drug discount program to keep its neonatal intensive care unit open. In Chicago, Mount Sinai Hospital Medical Center recently was able to help an uninsured patient cover the $20,000 cost of drug treatment for a parasite, thanks to its 340B savings. Because of 340B, Johnson County … [Read more...]
Faces of 340B: Help in Times of Crisis
June 21, 2018 – Two recent incidents perfectly illustrated to Hossam Gamal how the 340B program comes through in times of crisis – both for individuals and communities as a whole. When California’s Central Coast became one of the many regions in the nation to suffer a flu epidemic, Lompoc Valley Medical Center – where Gamal is the director of pharmacy services – was able to … [Read more...]
New Legislation Would Strengthen 340B Program, Demand Transparency, Accountability for Drug Makers
June 13, 2018—Newly introduced legislation would demand accountability and transparency from drug manufacturers participating in the 340B drug pricing program. The bill, sponsored by Rep. Doris Matsui (D-Calif.), is the most significant pro-340B proposal in nearly a decade. Under the Matsui bill, known as the Stretching Entity Resources for Vulnerable Communities (SERV … [Read more...]
Faces of 340B: A Story About Family
June 11, 2018 – For Sandy Clark, the 340B program is personal. She was inspired to become a 340B coordinator due to the experience of one special patient in particular – her own son. Sandy’s son was diagnosed with Hodgkin’s lymphoma in 2005, just a month before graduating from high school. At the time, Meadville Medical Center in northwestern Pennsylvania did not have the … [Read more...]